Doctor Hilman Amin

Doctor Hilman Amin

Universitas Indonesia, Jakarta (Indonesia)

Hilman Zulkifli Amin received an MD degree from Faculty of Medicine, Universitas Indonesia, Indonesia and subsequently complete PhD degree at the Division of Cardiovascular Medicine, Dept of Internal Medicine, Kobe University Graduate School of Medicine, Japan. His main research interest is the development of novel therapeutic strategy by using an immunological approach for the prevention and treatment of cardiovascular disease. He is an awardee of several prestigious awards such as Kobe University Young Investigator and PhD Excellence Award, First Prize Young Investigator Award of Asian Pacific Society of Cardiology and Japanese Circulation Society, Best Abstract of ESC, International Early Investigator Award and Paul Dudley White International Scholar Award of American Heart Association. He is a cardiologist-scientist trained in Japan and highly motivated to contribute and extend the advancement of cardiovascular medicine field hence reduce the burden of cardiovascular disease.

Presentations

Pharmacological inhibition of C-C chemokine receptor 4 aggravates atherosclerosis through prevention of regulatory T cell recruitment to the lesions

Event: ESC Congress 2020

Topic: Leukocytes, Inflammation, Immunity

Session: Basic Science Cardiac ePosters

Access

Overexpression of Cytotoxic T-Lymphocyte Associated Antigen-4 suppresses aortic immunoinflammatory responses and prevents angiotensin II-induced abdominal aortic aneurysm formation in mice.

Event: ESC Asia with APSC & AFC

Topic: Basic Science

Session: Best Abstracts from the Region at ESC Congress 2019 - 2

Access

Overexpression of Cytotoxic T-Lymphocyte Associated Antigen-4 suppresses aortic immunoinflammatory responses and prevents angiotensin II-induced abdominal aortic aneurysm formation in mice

Event: ESC Congress 2019

Topic: Leukocytes, Inflammation, Immunity

Session: Immune modulation in cardiovascular disease

Access

Pharmacological inhibition of C-C chemokine receptor 4 aggravates atherosclerosis through prevention of regulatory T cell recruitment to the lesions

Event: ESC Asia with APSC & AFC 2020

Topic: Leukocytes, Inflammation, Immunity

Session: Abstract Programme

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Hilman Amin

Biography

Contributor content

Pharmacological inhibition of C-C chemokine receptor 4 aggravates atherosclerosis through prevention of regulatory T cell recruitment to the lesions

Overexpression of Cytotoxic T-Lymphocyte Associated Antigen-4 suppresses aortic immunoinflammatory responses and prevents angiotensin II-induced abdominal aortic aneurysm formation in mice.

Overexpression of Cytotoxic T-Lymphocyte Associated Antigen-4 suppresses aortic immunoinflammatory responses and prevents angiotensin II-induced abdominal aortic aneurysm formation in mice

Pharmacological inhibition of C-C chemokine receptor 4 aggravates atherosclerosis through prevention of regulatory T cell recruitment to the lesions

ESC 365 is supported by

Doctor Hilman Amin Follow

Biography

Contributor content

Pharmacological inhibition of C-C chemokine receptor 4 aggravates atherosclerosis through prevention of regulatory T cell recruitment to the lesions

Overexpression of Cytotoxic T-Lymphocyte Associated Antigen-4 suppresses aortic immunoinflammatory responses and prevents angiotensin II-induced abdominal aortic aneurysm formation in mice.

Overexpression of Cytotoxic T-Lymphocyte Associated Antigen-4 suppresses aortic immunoinflammatory responses and prevents angiotensin II-induced abdominal aortic aneurysm formation in mice

Pharmacological inhibition of C-C chemokine receptor 4 aggravates atherosclerosis through prevention of regulatory T cell recruitment to the lesions

ESC 365 is supported by

Doctor Hilman Amin